CLINICAL COURSE OF A UNIQUE CASE OF ALLGROVE SYNDROME AND CHALLENGES OF HYPOGLYCEMIA MANAGEMENT.

Objective Allgrove syndrome (AS), also known as triple-A syndrome, is a rare disorder characterized by alacrima, achalasia, adrenal insufficiency, and other manifestations such as problems related to growth, puberty, and neuropsychological development. Although the genetics of this disorder have been studied extensively in recent decades, clinical information is still lacking. Methods We present a unique case of AS from which we have gained significant insight into its clinical course, especially the management of hypoglycemia. Results The patient initially presented with altered mental status at age 3 which was found to be due to hypoglycemia. Laboratory values confirmed primary adrenal insufficiency with isolated glucocorticoid deficiency. With additional history of alacrima, a genetic test was obtained which confirmed the diagnosis of AS. For over 10 years, we have been following her growth, puberty, and development. We experienced some challenges in managing her hypoglycemia initially. Certain metabolic effects of steroid overdose were noted. To resolve this problem, we found dextrose supplementation quite effective. Conclusion The rarity and isolated glucocorticoid deficiency of AS pose clinical challenges for initial diagnosis. Hypoglycemia associated with alacrima should alert the suspicion of AS. Management of hypoglycemia in AS is complicated by achalasia and may benefit from incorporation of both glucocorticoid and dextrose supplementation to prevent side effects of steroid overdose.

[1]  A. Brac de la Perrière,et al.  Triple-A syndrome: a wide spectrum of adrenal dysfunction. , 2017, European journal of endocrinology.

[2]  R. Jessberger,et al.  ALADIN is required for the production of fertile mouse oocytes , 2016, bioRxiv.

[3]  H. Kamoun,et al.  Clinical and Genetic Characterization of 26 Tunisian Patients with Allgrove Syndrome. , 2016, Archives of medical research.

[4]  F. Gottrand,et al.  Clinical and Manometric Characteristics of Allgrove Syndrome , 2011, Journal of pediatric gastroenterology and nutrition.

[5]  K. Koehler,et al.  Triple A syndrome: 32 years experience of a single centre (1977–2008) , 2010, European Journal of Pediatrics.

[6]  L. Metherell,et al.  The genetics of ACTH resistance syndromes. , 2006, Best practice & research. Clinical endocrinology & metabolism.

[7]  K. Koehler,et al.  A Novel AAAS Gene Mutation (p.R194X) in a Patient with Triple A Syndrome , 2006, Hormone Research in Paediatrics.

[8]  C. Stratakis,et al.  Genotypic heterogeneity and clinical phenotype in triple A syndrome: a review of the NIH experience 2000–2005 , 2005, Clinical genetics.

[9]  S. Hennig,et al.  Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. , 2001, Human molecular genetics.

[10]  H J Dean,et al.  Linkage of the gene for the triple A syndrome to chromosome 12q13 near the type II keratin gene cluster. , 1996, Human molecular genetics.

[11]  D B Grant,et al.  Neurological and adrenal dysfunction in the adrenal insufficiency/alacrima/achalasia (3A) syndrome. , 1993, Archives of disease in childhood.

[12]  K. Zerres,et al.  Three sibs with achalasia and alacrimia: a separate entity different from triple-A syndrome. , 1989, American journal of medical genetics.

[13]  G. Clayden,et al.  FAMILIAL GLUCOCORTICOID DEFICIENCY WITH ACHALASIA OF THE CARDIA AND DEFICIENT TEAR PRODUCTION , 1978, The Lancet.